CN Stock MarketDetailed Quotes

600566 Hubei Jumpcan Pharmaceutical

Watchlist
  • 39.56
  • -0.23-0.58%
Not Open May 17 15:00 CST
36.47BMarket Cap12.19P/E (TTM)

Hubei Jumpcan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
0.60%2.4B
7.32%9.65B
10.91%6.54B
19.82%4.63B
9.87%2.39B
17.90%9B
8.96%5.89B
4.92%3.86B
13.43%2.17B
23.77%7.63B
Operating revenue
0.60%2.4B
7.32%9.65B
10.91%6.54B
19.82%4.63B
9.87%2.39B
17.90%9B
8.96%5.89B
4.92%3.86B
13.43%2.17B
23.77%7.63B
Other operating revenue
----
-16.90%16.51M
----
-31.03%7.33M
----
52.79%19.87M
----
67.91%10.63M
----
-8.77%13M
Total operating cost
-6.58%1.59B
-1.57%6.52B
5.79%4.46B
13.82%3.21B
7.26%1.71B
12.93%6.62B
4.56%4.21B
2.69%2.82B
9.92%1.59B
24.07%5.86B
Operating cost
5.67%453.7M
16.04%1.78B
17.63%1.2B
31.27%850.08M
24.99%429.36M
20.43%1.54B
10.68%1.02B
4.03%647.58M
6.90%343.51M
12.94%1.28B
Operating tax surcharges
7.23%38.74M
5.35%146.24M
7.42%99.53M
17.58%70.62M
6.15%36.13M
14.81%138.81M
6.05%92.65M
0.15%60.06M
12.18%34.03M
21.03%120.9M
Operating expense
-9.14%989.65M
-2.58%4.01B
2.43%2.72B
10.12%2B
3.14%1.09B
10.74%4.11B
0.76%2.65B
0.18%1.82B
9.23%1.06B
23.40%3.71B
Administration expense
9.37%91.74M
2.34%372.78M
8.95%278.95M
7.74%180.87M
7.36%83.88M
14.94%364.24M
12.45%256.03M
13.99%167.88M
8.39%78.12M
9.27%316.89M
Financial expense
-142.36%-93.77M
-200.23%-257.49M
-191.61%-170.31M
-142.18%-104.93M
-155.61%-38.69M
3.60%-85.76M
-0.45%-58.4M
-5.79%-43.33M
30.13%-15.14M
-85.06%-88.97M
-Interest expense (Financial expense)
157.75%7.55M
-42.18%17.58M
-61.35%9.99M
-62.13%6.56M
-66.02%2.93M
-12.86%30.41M
0.10%25.84M
2.26%17.32M
5.39%8.62M
5.66%34.9M
-Interest Income (Financial expense)
-142.83%-101.6M
-135.97%-276.08M
-113.25%-180.96M
-83.29%-111.94M
-74.48%-41.84M
5.98%-117M
-0.58%-84.86M
-5.01%-61.07M
19.98%-23.98M
-52.38%-124.45M
Research and development
7.12%114.22M
-16.07%464.4M
32.50%334.6M
24.14%215.06M
12.92%106.63M
5.70%553.3M
14.54%252.53M
18.64%173.24M
20.24%94.43M
114.74%523.44M
Credit Impairment Loss
66.66%41.48M
108.86%3.23M
530.00%42.61M
184.85%36.54M
184.88%24.89M
-348.81%-36.39M
15.93%6.76M
7,287.88%12.83M
977.50%8.74M
-29.87%-8.11M
Other net revenue
-1.13%77.66M
150.85%120.06M
56.56%146.35M
77.02%116.44M
182.91%78.54M
-71.00%47.86M
14.05%93.48M
48.07%65.78M
6.69%27.76M
459.97%165M
Fair value change income
-22.62%16.23M
299.63%14.6M
-30.76%15.54M
9.55%20.9M
27.36%20.98M
-106.39%-7.32M
-35.87%22.44M
-5.74%19.08M
6.30%16.47M
447.02%114.55M
Invest income
-47.20%14.74M
23.43%81.72M
86.92%76.64M
227.35%51.33M
5,342.07%27.93M
40.94%66.21M
27.74%41M
-15.80%15.68M
-108.14%-532.73K
3,337.85%46.98M
-Including: Investment income associates
----
219.34%2.46M
----
----
----
14.08%769.49K
----
----
----
375.51%674.51K
Asset deal income
-106.37%-5.94K
-97.50%130.28K
-98.52%100.94K
-98.62%93.33K
1,509.03%93.33K
698.58%5.22M
1,033.04%6.82M
18,664.17%6.78M
-118.34%-6.62K
-80.48%653.3K
Other revenue
11.72%5.2M
1.17%20.37M
-30.40%11.46M
-33.64%7.57M
50.50%4.66M
84.30%20.14M
94.99%16.46M
113.43%11.41M
-1.46%3.09M
8.67%10.93M
Operating profit
16.52%885.93M
34.44%3.26B
25.51%2.22B
38.56%1.53B
24.55%760.34M
25.39%2.42B
21.39%1.77B
13.14%1.11B
23.35%610.47M
31.58%1.93B
Add:Non operating Income
240.81%103.97M
-56.62%41.64M
-61.47%36.06M
-63.39%32.44M
-62.05%30.51M
370.94%95.99M
558.23%93.57M
551.88%88.6M
664.74%80.38M
-4.30%20.38M
Less:Non operating expense
-92.47%100.59K
-76.75%2.69M
-86.44%1.16M
-73.62%2.15M
-82.12%1.34M
317.07%11.57M
544.40%8.58M
918.05%8.16M
3,666.71%7.47M
-58.95%2.77M
Total profit
25.37%989.79M
31.47%3.3B
21.64%2.26B
31.72%1.56B
15.53%789.51M
28.58%2.51B
26.10%1.86B
19.80%1.19B
35.27%683.38M
31.47%1.95B
Less:Income tax cost
28.43%143M
39.80%470.03M
18.16%312.2M
29.48%220.41M
9.26%111.35M
44.16%336.2M
31.08%264.21M
24.90%170.23M
54.17%101.92M
13.05%233.22M
Net profit
24.87%846.79M
30.18%2.83B
22.22%1.95B
32.09%1.34B
16.63%678.16M
26.47%2.17B
25.31%1.59B
18.99%1.02B
32.42%581.46M
34.45%1.72B
Net profit from continuing operation
24.87%846.79M
30.18%2.83B
22.22%1.95B
32.09%1.34B
16.63%678.16M
26.47%2.17B
25.31%1.59B
18.99%1.02B
32.42%581.46M
34.45%1.72B
Less:Minority Profit
8.59%1.52M
341.93%4.28M
165.02%3.22M
418.17%2.21M
407.82%1.4M
149.45%968.89K
350.42%1.22M
--427.25K
--275.78K
---1.96M
Net profit of parent company owners
24.90%845.27M
30.04%2.82B
22.11%1.94B
31.93%1.34B
16.44%676.76M
26.27%2.17B
25.17%1.59B
18.94%1.02B
32.36%581.19M
34.60%1.72B
Earning per share
Basic earning per share
24.90%0.923
26.23%3.08
18.47%2.123
28.00%1.463
13.00%0.739
25.77%2.44
25.14%1.792
18.94%1.143
32.39%0.654
26.80%1.94
Diluted earning per share
24.76%0.922
28.87%3.08
19.92%2.119
29.52%1.461
15.11%0.739
25.13%2.39
24.61%1.767
18.61%1.128
31.29%0.642
24.84%1.91
Other composite income
Total composite income
24.87%846.79M
30.18%2.83B
22.22%1.95B
32.09%1.34B
16.63%678.16M
26.47%2.17B
25.31%1.59B
18.99%1.02B
32.42%581.46M
34.45%1.72B
Total composite income of parent company owners
24.90%845.27M
30.04%2.82B
22.11%1.94B
31.93%1.34B
16.44%676.76M
26.27%2.17B
25.17%1.59B
18.94%1.02B
32.36%581.19M
34.60%1.72B
Total composite income of minority owners
8.59%1.52M
341.93%4.28M
165.02%3.22M
418.17%2.21M
407.82%1.4M
149.45%968.89K
350.42%1.22M
--427.25K
--275.78K
---1.96M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 0.60%2.4B7.32%9.65B10.91%6.54B19.82%4.63B9.87%2.39B17.90%9B8.96%5.89B4.92%3.86B13.43%2.17B23.77%7.63B
Operating revenue 0.60%2.4B7.32%9.65B10.91%6.54B19.82%4.63B9.87%2.39B17.90%9B8.96%5.89B4.92%3.86B13.43%2.17B23.77%7.63B
Other operating revenue -----16.90%16.51M-----31.03%7.33M----52.79%19.87M----67.91%10.63M-----8.77%13M
Total operating cost -6.58%1.59B-1.57%6.52B5.79%4.46B13.82%3.21B7.26%1.71B12.93%6.62B4.56%4.21B2.69%2.82B9.92%1.59B24.07%5.86B
Operating cost 5.67%453.7M16.04%1.78B17.63%1.2B31.27%850.08M24.99%429.36M20.43%1.54B10.68%1.02B4.03%647.58M6.90%343.51M12.94%1.28B
Operating tax surcharges 7.23%38.74M5.35%146.24M7.42%99.53M17.58%70.62M6.15%36.13M14.81%138.81M6.05%92.65M0.15%60.06M12.18%34.03M21.03%120.9M
Operating expense -9.14%989.65M-2.58%4.01B2.43%2.72B10.12%2B3.14%1.09B10.74%4.11B0.76%2.65B0.18%1.82B9.23%1.06B23.40%3.71B
Administration expense 9.37%91.74M2.34%372.78M8.95%278.95M7.74%180.87M7.36%83.88M14.94%364.24M12.45%256.03M13.99%167.88M8.39%78.12M9.27%316.89M
Financial expense -142.36%-93.77M-200.23%-257.49M-191.61%-170.31M-142.18%-104.93M-155.61%-38.69M3.60%-85.76M-0.45%-58.4M-5.79%-43.33M30.13%-15.14M-85.06%-88.97M
-Interest expense (Financial expense) 157.75%7.55M-42.18%17.58M-61.35%9.99M-62.13%6.56M-66.02%2.93M-12.86%30.41M0.10%25.84M2.26%17.32M5.39%8.62M5.66%34.9M
-Interest Income (Financial expense) -142.83%-101.6M-135.97%-276.08M-113.25%-180.96M-83.29%-111.94M-74.48%-41.84M5.98%-117M-0.58%-84.86M-5.01%-61.07M19.98%-23.98M-52.38%-124.45M
Research and development 7.12%114.22M-16.07%464.4M32.50%334.6M24.14%215.06M12.92%106.63M5.70%553.3M14.54%252.53M18.64%173.24M20.24%94.43M114.74%523.44M
Credit Impairment Loss 66.66%41.48M108.86%3.23M530.00%42.61M184.85%36.54M184.88%24.89M-348.81%-36.39M15.93%6.76M7,287.88%12.83M977.50%8.74M-29.87%-8.11M
Other net revenue -1.13%77.66M150.85%120.06M56.56%146.35M77.02%116.44M182.91%78.54M-71.00%47.86M14.05%93.48M48.07%65.78M6.69%27.76M459.97%165M
Fair value change income -22.62%16.23M299.63%14.6M-30.76%15.54M9.55%20.9M27.36%20.98M-106.39%-7.32M-35.87%22.44M-5.74%19.08M6.30%16.47M447.02%114.55M
Invest income -47.20%14.74M23.43%81.72M86.92%76.64M227.35%51.33M5,342.07%27.93M40.94%66.21M27.74%41M-15.80%15.68M-108.14%-532.73K3,337.85%46.98M
-Including: Investment income associates ----219.34%2.46M------------14.08%769.49K------------375.51%674.51K
Asset deal income -106.37%-5.94K-97.50%130.28K-98.52%100.94K-98.62%93.33K1,509.03%93.33K698.58%5.22M1,033.04%6.82M18,664.17%6.78M-118.34%-6.62K-80.48%653.3K
Other revenue 11.72%5.2M1.17%20.37M-30.40%11.46M-33.64%7.57M50.50%4.66M84.30%20.14M94.99%16.46M113.43%11.41M-1.46%3.09M8.67%10.93M
Operating profit 16.52%885.93M34.44%3.26B25.51%2.22B38.56%1.53B24.55%760.34M25.39%2.42B21.39%1.77B13.14%1.11B23.35%610.47M31.58%1.93B
Add:Non operating Income 240.81%103.97M-56.62%41.64M-61.47%36.06M-63.39%32.44M-62.05%30.51M370.94%95.99M558.23%93.57M551.88%88.6M664.74%80.38M-4.30%20.38M
Less:Non operating expense -92.47%100.59K-76.75%2.69M-86.44%1.16M-73.62%2.15M-82.12%1.34M317.07%11.57M544.40%8.58M918.05%8.16M3,666.71%7.47M-58.95%2.77M
Total profit 25.37%989.79M31.47%3.3B21.64%2.26B31.72%1.56B15.53%789.51M28.58%2.51B26.10%1.86B19.80%1.19B35.27%683.38M31.47%1.95B
Less:Income tax cost 28.43%143M39.80%470.03M18.16%312.2M29.48%220.41M9.26%111.35M44.16%336.2M31.08%264.21M24.90%170.23M54.17%101.92M13.05%233.22M
Net profit 24.87%846.79M30.18%2.83B22.22%1.95B32.09%1.34B16.63%678.16M26.47%2.17B25.31%1.59B18.99%1.02B32.42%581.46M34.45%1.72B
Net profit from continuing operation 24.87%846.79M30.18%2.83B22.22%1.95B32.09%1.34B16.63%678.16M26.47%2.17B25.31%1.59B18.99%1.02B32.42%581.46M34.45%1.72B
Less:Minority Profit 8.59%1.52M341.93%4.28M165.02%3.22M418.17%2.21M407.82%1.4M149.45%968.89K350.42%1.22M--427.25K--275.78K---1.96M
Net profit of parent company owners 24.90%845.27M30.04%2.82B22.11%1.94B31.93%1.34B16.44%676.76M26.27%2.17B25.17%1.59B18.94%1.02B32.36%581.19M34.60%1.72B
Earning per share
Basic earning per share 24.90%0.92326.23%3.0818.47%2.12328.00%1.46313.00%0.73925.77%2.4425.14%1.79218.94%1.14332.39%0.65426.80%1.94
Diluted earning per share 24.76%0.92228.87%3.0819.92%2.11929.52%1.46115.11%0.73925.13%2.3924.61%1.76718.61%1.12831.29%0.64224.84%1.91
Other composite income
Total composite income 24.87%846.79M30.18%2.83B22.22%1.95B32.09%1.34B16.63%678.16M26.47%2.17B25.31%1.59B18.99%1.02B32.42%581.46M34.45%1.72B
Total composite income of parent company owners 24.90%845.27M30.04%2.82B22.11%1.94B31.93%1.34B16.44%676.76M26.27%2.17B25.17%1.59B18.94%1.02B32.36%581.19M34.60%1.72B
Total composite income of minority owners 8.59%1.52M341.93%4.28M165.02%3.22M418.17%2.21M407.82%1.4M149.45%968.89K350.42%1.22M--427.25K--275.78K---1.96M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg